NasdaqGS:TXGLife Sciences
10x Genomics (TXG) Is Up 14.6% After Analyst Upgrade Highlights AI-Scale Spatial Genomics Initiative
On March 31, 2026, William Blair upgraded 10x Genomics from “Market Perform” to “Outperform,” citing its best-in-class genomics technology and improving execution.
The upgrade highlighted a multinational Xenium-based spatial transcriptomics initiative targeting up to 100,000 patient tissue samples, underscoring 10x Genomics’ role in supplying AI-scale biological datasets.
Next, we’ll examine how this AI-focused spatial data initiative may reshape 10x Genomics’ investment narrative and...